DEFA14A ·Filed Apr 14, 2026

LMAT

LEMAITRE VASCULAR INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed5mo ago SEC0001193125-26-153881
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for any unexpected director nominations or shareholder proposals in future filings, but this is a standard proxy statement following a minor board reshuffle.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
LMAT ▼ -12.77% at T+60d
NEUTRAL call ✗ call lost -12.77% · α vs SPY -21.29% · entry $117.39 → $102.40
Entry anchored
Apr 13, 03:59 PM ET
via exchange tick
T+1d
-2.20%
call -2.20% · α -2.97%
$114.81
settled 6mo ago
T+5d
-4.68%
call -4.68% · α -6.07%
$111.90
settled 5mo ago
T+20d
-13.42%
call -13.42% · α -19.71%
$101.64
settled 5mo ago
T+60d
-12.77%
call -12.77% · α -21.29%
$102.40
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

LeMaitre Vascular filed a definitive proxy statement for its 2026 Annual Meeting, where shareholders will vote on the election of two directors, approval of executive compensation, and ratification of the independent auditor. This follows a recent board change where a director stepped down and was replaced, indicating a board reshuffling.

Key Facts

  • 2026 Annual Meeting will be held on June 2, 2026
  • Proposals include election of two directors, approval of executive compensation, and ratification of the auditor
  • Board size reduced from eight to seven members
  • Director Bridget Ross will not stand for re-election
  • David B. Roberts nominated to fill the Class II seat

Financial Impact

Routine governance changes with no immediate financial impact

board compositionexecutive compensationaudit firm

Risk Factors

  • Potential for unexpected shareholder activism if more filings emerge
  • Risk of negative vote on executive compensation if compensation is perceived as excessive

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-153881
Document: 0001193125-26-153881-index-headers.html0001193125-26-153881
Document: 0001193125-26-153881-index.html0001193125-26-153881
Document: 0001193125-26-153881.txt0001193125-26-153881
11 reports for LMAT
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +17.70%Jul 14, 2026
Filters
Rows
Reports for LMAT — sortable, filterable
TypeNow
Aug 27, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$80.45 $82.34▲ +2.35%▲ +2.09%$78.78 (−2.08%)
Jul 14, 2026
11w ago
Press Release
BEARISH ★ 7/10
$99.79 $82.13▲ +17.70%▲ +20.04%$78.78 (+21.06%)
May 7, 2026
21w ago
Insider Cluster
BEARISH ★ 4/10
$107.91 $91.64▲ +15.08%▲ +18.21%$78.78 (+27.00%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.78 (−27.00%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.78 (−27.00%)
May 5, 2026
21w ago
8-K
BULLISH ★ 7/10
$110.22 $91.64▼ −16.86%▼ −19.64%$78.78 (−28.53%)
Apr 14, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.78 (−32.89%)
Apr 14, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.78 (−32.89%)
Mar 11, 2026
29w ago
Insider Cluster
NEUTRAL ★ 3/10
$108.09 $112.71▲ +4.27%▲ +3.75%$78.78 (−27.12%)
Feb 26, 2026
31w ago
Insider Cluster
BEARISH ★ 7/10
$113.43 $110.33▲ +2.73%▼ −3.67%$78.78 (+30.55%)
Showing 10 of 11

US Market Status

Market Open — Closes in 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access